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INTRODUCTION
Bronchial asthma is the most common chronic respiratory
disorder, and is characterized by the hyper-responsiveness of
the tracheobronchial tree to a multiplicity of stimuli. The
prevalence of bronchial asthma is rising in many industrial-
ized parts of the world, and air pollution may be a cause of
this increasing prevalence (1).
Air pollution plays a major role in the pathogenesis of asth-
ma, and many studies have revealed that air pollutants such
as ozone (O3), nitric oxides (NOx), sulfur dioxide (SO2), car-
bon monoxide (CO), particulate matter (PM), and environ-
mental tobacco smoke (ETS) produce adverse effects on the
symptoms and pulmonary function of both asthmatic and
non-asthmatic subjects. In addition, increased levels of these
air pollutants have been associated with increased emergen-
cy department admissions (2-4).
Ozone is known to cause allergen-induced inflammation
by initiating a Th2 response or by exacerbating airway inflam-
mation in patients who are already sensitized to an allergen
(5-7). Ozone is a by-product of atmospheric reactions that
require nitrogen oxide, volatile organic compounds such as
hydrocarbon, and ultraviolet light. Automobile exhaust is
the most significant source for outdoor nitrogen dioxide (5).
Thus, ozone is elevated in urban areas with a heavy traffic
volume and substantial amount of sunlight. Studies on the
association between the ozone concentration and the clinical
manifestations of asthmatics have been performed, but the
ozone concentrations have all been measured in specific down-
town area locations where one would logically predict a higher
ozone concentration. In addition, with the expansion of auto-
mobile traffic, the modern boundary of higher ozone concen-
trations is not limited to a specific area but is much broader,
beyond the limits of downtown air monitors. Thus, ozone
concentrations measured by air monitors in downtown areas
may not reflect the actual ozone concentration to which asth-
matics are exposed and cannot adequately explain the changes
in symptoms and lung function parameters of patients with
asthma.
Developing regions often face critical air pollution prob-
lems because of rapid growth in traffic volume and popula-
tion density. Recently, the midsection of Korea has become
increasingly urbanized, and some regions have begun to face
air quality problems. Using a passive ozone sampler, we mea-
sured the individual levels of ozone exposure of asthmatics
in two medium-sized cities in Korea and evaluated the effects
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The Effects of On-site Measured Ozone Concentration on Pulmonary
Function and Symptoms of Asthmatics
Most studies on the effects of ambient ozone on asthmatics have been based on
ozone concentration measurements taken by air monitors in downtown areas. Using
a passive ozone sampler, we investigated the effects of on-site ozone concentra-
tions on the pulmonary function and symptoms of asthmatics. Twenty moderate to
severe asthmatics who had been managed for at least 2 months without changes
of their medication were enrolled from 3 June to 18 July 2005. Respiratory, nasal
and ocular symptoms, peak expiratory flow (PEF), which was measured twice a
day, and medication use were recorded on a daily basis during the study period.
Data for 17 subjects were analyzed. The average ozone exposure level was 28.2
± ±23.6 ppb (3.4-315.3 ppb). There was no significant correlation between PEF and
ozone concentration (p>0.05) on the same day or 1-, 2-, or 3-day lags. Interestingly,
the degree of asthma symptoms was influenced by the ozone concentration ( =
0.303, p<0.001), even at concentrations less than 80 ppb (p=0.298, p<0.001), but
the correlation between ozone exposure and the frequency of reliever medication
use was not statistically significant (p=0.99). Our results suggest that exposure to
relatively low concentrations of ozone influences the symptoms of moderate to severe
asthmatics regardless of changes in pulmonary function or medication use.
Key Words : Air Pollution; Asthma; Ozone
Received : 16 March 2006
Accepted : 14 July 2006Personal Ozone Exposure and Symptoms of Asthmatics 31
of the measured ozone concentration on the symptoms, pul-
monary function parameters, and medication use of the asth-
matics.
MATERIAL AND METHODS
Study population
Twenty asthmatics who were residents of Cheonan or Che-
ongju were recruited from 3 June to 18 July 2005, and the
ozone concentration to which each person was exposed was
measured for 31 days. All the subjects were given personal
logs and pocket peak flow meters to record peak expiratory
flow (PEF) and changes in asthma symptoms or medication
use on a daily basis during the same period. All the patients
had been diagnosed with bronchial asthma according to the
guidelines of the American Thoracic Society (8) and had been
managed for at least 2 months without changes in their med-
ication before they were enrolled to this study. Ten patients
were registered at Dankook University Hospital in Cheonan
city, and the other ten patients were registered at Cheongju
St. Mary’s Hospital in Cheongju city. Patients with active
pulmonary infection, lung cancer, congestive heart failure,
or chronic renal failure or who were active smokers were ex-
cluded from the study. Asthmatics taking oral or systemic
corticosteroid were also excluded.
All subjects underwent a bronchodilator test and ten pati-
ents underwent a methacholine provocation test to confirm
reversible airflow limitation and airway hyperreactivity. A
skin prick test was performed according to the individual
clinical manifestations, and baseline PFT were obtained before
subjects were enrolled. Thirteen patients were severe-persis-
tent and seven patients were moderate-persistent in terms
of severity, as classified by the symptoms, pulmonary func-
tion, and treatment according to the 2002 GINA guideline.
All the subjects had been managed with medications, such
as inhaled corticosteroids, long-acting  2-agonists, and oral
theophylline, according to the severity of their asthma before
they were enrolled. The subjects were allowed to use relief
medication, such as a short-acting  2-agonist, when they
experienced episodic symptoms of cough, sputum, wheez-
ing, shortness of breath, morning chest tightness, or other
asthma symptoms. A questionnaire that included demogra-
phic data, medical history, medication use, and smoking his-
tory was provided to each study subject, and personal logs
were provided so the subjects could record any of their res-
piratory symptoms and additional symptoms. The personal
logs were accepted for analysis if the data covered at least
two-thirds of the study period. Informed consent for the
study protocol was obtained from all patients, and the study
motocol was approved by the ethics committee of Dankook
Medical Center.
Ozone concentration measurement
A passive sampler (ozone PSs; R&D Center, Envors, Dae-
geon, Korea) was used to evaluate the ozone concentrations
to which the subjects were exposed and p-acetamidophenol,
which reacts specifically with ambient ozone to produce a
fluorescent material, was used as the reagent in the passive
sampler. This passive ozone sampler was developed to mea-
sure the ambient ozone concentrations at several sites, and
field validation tests indicated that the results from the pas-
sive ozone sampler correlated (r=0.963) with a UV photo-
metric O3 analyzer, which is the standard equipment used
for measuring ambient ozone concentrations in Korea (9). The
passive samplers were distributed to the study subjects, and
the subjects were told to attach a new sampler to their clothes
every day and to return the ozone samplers to the hospital
at least every 15 days. The samplers were then delivered to
the R&D Center of Envors and analyzed using a fluorescence
spectrometer (Hitachi F2500, Tokyo, Japan).
Patient log of asthmatic and allergic symptoms
Study subjects were asked to record the degree of their as-
thma symptoms (cough, sputum, wheezing, shortness of breath,
morning chest tightness), and other symptoms (rhinorrhea,
ocular irritation, and febrile sensation) at the end of each day.
The patients subjectively graded their symptoms as none,
mild, moderate, or severe and recorded the grade as a num-
ber, 0, 1, 2, or 3, respectively. The total asthma symptom score
was obtained by adding each daily asthma symptom score
and used to analyze the statistical relationship between the
subject’s ozone concentration exposure and asthma symptoms.
The frequency of using relief medications was also recorded.
Measuring pulmonary function
The subjects were taught a standard method for using a
pocket peak flow meter and were asked to take PEF measure-
ments in triplicate in the morning and evening during the
study period. The highest of the three values was recorded.
The mean PEF and PEF variability were derived and calcu-
lated from the patient’s log according to the following for-
mulas:
Mean PEF=(Morning PEF+Evening PEF)/2
PEF variability=2×100 (%)×(Maximum PEF-Minimum
PEF)/(Maximum PEF+Minimum PEF)
Statistical analysis
To define the associations between the ozone concentration
and the degree of symptoms, pulmonary function parameters,
and the frequency of reliever medication use, we obtained
daily average levels of ozone from a passive ozone sampler,
which was distributed to each study subject. Each subject’s32 D.H. Kim, Y.S. Kim, J.S. Park, et al.
morning PEF, evening PEF, mean PEF, and percent variability
in PEF were measured on a daily basis during the study peri-
od to gauge the pulmonary function. The ozone concentra-
tion was compared with each pulmonary function parameter
on the current day and for 1-, 2-, and 3-day lags because the
bronchial responses of asthmatic patients to ozone can be
delayed. To evaluate the influence of ozone on the degree of
asthma symptoms, total asthma symptom scores as well as
each symptom score were compared with the level of ozone
concentration on the current day. Furthermore, we evaluated
the frequency of reliever medication use based on the ozone
concentration in the same manner. SPSS version 11.5 (SPSS,
Chicago, IL, U.S.A.) was used for data analysis, and Pearson’s
correlation analysis and Spearman’s rho were used for statis-
tical comparisons.
RESULTS
Subjects
Twenty subjects were enrolled in the study, but three sub-
Characteristics Data
Male/Female (n) 8/9
Age (yr)* 45.4±15.3 (25-73)
Smoking
Current smoker 0
Ex-smoker 0
Nonsmoker 17
Atopic/non-atopic 8/9
Residential district
Agricultural district 1
Small town 6
Downtown 9
Factory district 1
O3 (ppb)* 28.2±23.6 (3.4-315.3)
Baseline PFT
�
FEV1 (predicted %)* 84.3±13.8 (62-110.7)
FVC (predicted %)* 90.9±13.6 (69-118.8)
Positive bronchodilator test 17
PC20-methacholine (mg/mL)
� 3.24±2.03
Table 1. Characteristics of the study subjects
*, Data are presented as the mean±SD (range); 
� , Data are presented
as the geometric mean±SD; 
� , Baseline PFT was measured just before
the subjects were enrolled.
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Fig. 1. Pulmonary function (PEF and PEF % variability) according to the concentration of O3 measured on-site. 
PEF, peak expiratory flow.
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jects were excluded because their data did not cover two-thirds
of the study period. Consequently, 17 subjects (8 male, 9 fe-
male; mean age: 45.4±15.3 yr) were included for analysis.
The skin prick test was positive for more than one allergen
in eight subjects. Bronchodilator tests were all positive and
the mean geometric PC20-methacholine was 3.24±2.03 mg/
mL. The ozone concentration, which was analyzed by a flu-
orescence spectrometer (Hitachi F2500), showed that the
average daily ozone concentration during the study period was
28.2±23.6 (3.4-315.3) ppb. Baseline demographic data,
including baseline pulmonary function measurements, are
presented in Table 1. 
Correlation of changes in pulmonary function with ozone
exposure
To define the relationship between the ozone concentration
and changes in pulmonary function, we compared the indi-
vidually measured ozone exposure levels to each pulmonary
function parameter, including the morning PEF (% predict-
ed), evening PEF (% predicted), mean PEF (% predicted),
and PEF (% variability). When the relationships between the
PEF and ozone levels in general or individually on the cur-
rent day were analyzed, no statistically significant correlation
was found, although the morning, evening, and mean PEF
values had a decreasing tendency according to the level of
ozone concentration (p>0.05; Fig. 1). The data were also sim-
ilar when the pulmonary function parameters associated with
two extreme ozone levels (228 and 315.3 ppb) were excluded.
1-day lag 2-day lag 3-day lag
Morning PEF r=-0.04 r=0.00 r=-0.06
(% predicted) p=0.37 p=0.97 p=0.24
Evening PEF r=-0.04 r=-0.01 r=-0.02
(% predicted) p=0.44 p=0.79 p=0.62
Mean PEF r=-0.05 r=-0.01 r=-0.05
(% predicted) p=0.34 p=0.89 p=0.35
% variability r=-0.11 r=-0.07 r=0.06
p=0.02* p=0.14 p=0.20
Table 2. Correlation analysis of O3, PEF (% predicted), and PEF
(% variability) for 1-, 2-, and 3-day lags
*p<0.05, statistically significant.
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Fig. 2. (A) Total asthma symptom score according to the O3 level. (B) Total asthma symptom score according to the O3 level (>80 ppb).
Correlation analysis revealed a statistically significant positive correlation with moderate strength. (C) Total asthma symptom score accord-
ing to the O3 level (<80 ppb), which still represents a statistically significant positive correlation, although weaker. (D) Correlation analysis
showed an even weaker correlation with very low  when exposed to O3 below 30 ppb.
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The level of ozone concentration with each pulmonary func-
tion parameter on 1-, 2-, and 3-day lags was compared to
evaluate any delayed effects of ozone on asthmatic airways.
Although the PEF (% variability) for the 1-day lag was sta-
tistically significant, it was not relevant clinically (r=-0.11,
p=0.02; Table 2). In addition, the correlational analyses bet-
ween the ozone concentration and other pulmonary function
parameters for the 1-, 2-, and 3-day lags did not show any
significant differences (Table 2).
Correlation of asthma symptoms with ozone exposure
Total asthma symptom scores according to the daily aver-
age level of ozone on the current day were analyzed to define
the association between the ozone concentration and the level
of asthma symptoms. Although there was no significant cor-
relation between the level of ozone concentration and PEF,
the total asthma symptom score increased when subjects were
exposed to a higher ozone concentration. Correlational anal-
ysis revealed that there was a weak, but statistically positive,
correlation between the level of ozone concentration and the
total asthma symptom score (r=0.303, p<0.001; Fig. 2A). In
addition, when the influence of ozone concentrations above
and below 80 ppb on the total asthma symptom scores was
evaluated, a significant positive correlation was noted when
exposed to ozone levels above 80 ppb ( =0.582, p=0.037;
Fig. 2B), and there was a weak positive correlation when ex-
posed to ozone levels less than 80 ppb ( =0.298, p<0.001;
Fig. 2C). The strength of the positive correlation decreased
with the exposed ozone concentration (Fig. 2D). There was
no statistically significant correlation for the 1-, 2-, or 3-day
lags (p>0.05). Each asthma symptom, nasal symptom, and
ocular symptom was also analyzed, and the correlation analy-
sis revealed weak positive correlations for morning chest tight-
ness and dyspnea with the exposed ozone in general (Table
3). These results suggest that the degree of asthma symptoms
is influenced by the level of ozone concentration exposure,
even at ozone concentrations below 80 ppb.
Correlation of the frequency of inhaler medications use
with ozone exposure
Although the total symptom score was influenced by changes
in the level of ozone concentration, a statistically significant
correlation between the level of ozone exposure and the fre-
quency of reliever medication use was not observed (r=-0.001,
p=0.99; Fig. 3).
DISCUSSION
Although numerous studies have examined the effect of
ozone on asthmatics, the ozone concentrations were measured
in specific areas without considering the individual’s site-spe-
cific ozone exposure level. Our study examined the on-site
level of ozone and the influences of daily personal ozone expo-
sure on the symptoms and lung function in asthmatics; to our
knowledge, no other study has used subject-borne passive
ozone samplers. The on-site measured level of ozone was not
high in the midsection of two medium-sized cities in Korea.
Some articles have suggested that there is a time lag between
increased ozone levels and their effects, and the development
of airway inflammation in response to ozone exposure might
occur during this time lag (10). In addition, one study found
a statistically significant association between emergency room
visits and mean O3 levels, on the day of admission and also
on days 2 and 3 (11). In contrast to most of the studies that
have already been performed, changes in the level of ambient
ozone did not induce significant changes in the PEF or PEF
variability for the current day or 1-, 2-, or 3-day lags in our
study. These results may have occurred because the average
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Fig. 3. Frequency of reliever medication use according to O3 level.
r=-0.001
p=0.99
Patient symptoms
Exposed O3 level
O3 (total) O3 >80 ppb O3 <80 ppb
Cough =0.185 =0.614 =0.179
p<0.001* p=0.026* p<0.001*
Sputum =0.085 =0.593 =0.085
p=0.062 p=0.033* p=0.066
Morning chest tightness =0.245 =0.246 =0.250
p<0.001* p=0.418 p<0.001*
Dyspnea =0.340 =0.246 =0.311
p<0.001* p=0.418 p<0.001*
Wheezing =0.172 =0.413 =0.196
p<0.001* p=0.111 p<0.001*
Rhinorrhea =-0.114 =0.472 =-0.098
p=0.013* p=0.104 p=0.034*
Eye irritation =0.123 =0.463 =0.149
p=0.007* p=0.111 p=0.001*
Table 3. Correlation analysis of exposed O3 level, each asthma
symptom, nasal symptom, and ocular symptoms
*p<0.05, statistically significant.Personal Ozone Exposure and Symptoms of Asthmatics 35
ozone concentration during our study was only 29.4±24.4
ppb, whereas the level of ozone in the prior studies was higher,
at least 100 ppb.
However, the total asthma symptom scores had a linear
association with the ozone concentration. Our data showed
that as the level of ozone exposure increased, the total symp-
tom score increased, and this increase in the total symptom
score was observed even at ozone concentrations below 80
ppb; however, the symptoms might not have been severe since
there was no increase in reliever medication use. The strength
of the correlation decreased with the decrement in the exposed
ozone level. This level of ozone concentration has been previ-
ously considered to be too low to cause respiratory symptoms
in non-asthmatics. The results suggest that asthma symptoms
are provoked or aggravated by the ozone concentration, even
at concentrations below 80 ppb, at least in patients with mo-
derate to severe persistent asthma. There is also a chance that
the quality of life for asthmatic patients is being deleteriously
affected by these low levels of ozone.
Numerous studies have already documented the effects of
ozone on asthmatics, such as increases in morbidity, emer-
gency department visits, mortality, and the prevalence of as-
thma. During the 1996 Olympic Games in Atlanta, a 13%
reduction in the ozone concentration reduced acute asthmatic
events in children, and increases in daily acute asthmatic events
was associated with levels of the 1-hr ozone concentration from
60 to 89 ppb (12). Summer asthma camp studies, seeking
to define the association between daily ozone levels and lung
function, have also observed linear decreases in the PEF and
FEV1 associated with 1-hr ozone concentrations. This study
showed that a 0.5% decrease in the PEF accompanied a 15
ppb increase in ozone (13). The influence of ozone is more
profound in patients with persistent asthma. A study involv-
ing patients with persistent asthma who had been taking
maintenance medications revealed that patients with persis-
tent asthma were more vulnerable to ozone and that an 8%
increase of coughing in children with persistent asthma acco-
mpanied a 50 ppb increase in the ozone level on the current
or previous day (14). Repeated exposure to ozone at a peak
ambient air level can enhance the inflammatory responses to
inhaled allergens in subjects with preexisting allergic airway
disease (15). The exposure of subjects with mild allergic asth-
ma to an ozone level sufficient to cause modest decreases in
lung function increased the reactivity to allergens (16).
Many studies have attempted to determine the underlying
mechanisms of the harmful effects of various pollutants. Ozone
has been found to induce a neutrophilic inflammatory res-
ponse in the airway that can persist up to 24 hr after exposure
(17). Recent research has focused on the specific effects of
various pollutants at clinically relevant levels of exposure in
susceptible individuals. Some studies investigated the effects
of ozone exposure in subjects with mild asthma who had a
prior allergen challenge and found that the percentage of
eosinophils was significantly higher after exposure to ozone,
suggesting that ozone exposure potentiates the eosinophilic
response of the airways induced by allergen inhalation in pa-
tients with asthma (18). Furthermore, a study on bronchial
cytokine expression induced by ozone exposure in both healthy
and asthmatic subjects showed significantly increased expres-
sion levels of interleukin (IL)-5 and granulocyte macrophage
colony-stimulating factor in the asthmatic group (19). These
results imply that a worsening of airway inflammation can
be caused by up-regulation of Th2-related cytokines when
exposed to clinically relevant ozone levels, and this response
is only found in the asthmatic airways. Recently, some stud-
ies have suggested that the effects of ozone can be amplified
by co-exposure with urban dust, such as carbon black parti-
cles in diesel exhaust. The carbon black particles possibly act
as a carrier for ozone to distal lung areas that are not usually
accessible to ozone in the gaseous phase, or the ozone might
alter the physicochemistry of the particulates from a nontoxic
to a toxic form (20). According to a study using a mouse asth-
ma model, methacholine-induced Penh and interleukin (IL)-
4, neutrophils, and eosinophils in BAL fluids increased more
in the allergen (OVA)-sensitized-challenged and the ozone
and diesel exhaust particles (DEP) exposure group than in
the allergen (OVA)-sensitized-challenged and ozone exposure
group (21). These findings suggest that ozone and DEP have
an additive effect on airway hyper-responsiveness in murine
asthma models and that the mechanism responsible for in-
creased hyper-responsiveness contributes to the Th2 immune
responses (21). Since our results were analyzed according to
the individual on-site ozone concentrations, the results would
not reflect the effects of other air pollutants, including PM,
NO2, and SO2. Therefore, the changes in the asthma symp-
toms in our study might have been overestimated or biased.
In summer, the concentrations of air pollutants other than
ozone are relatively low. The levels of SO2, NO2, and PM10
during the study period were well below the national stan-
dards. The respective monthly averages of SO2, NO2, and
PM10 in June were 0.004 ppm, 0.018 ppm, and 61  g/m3
in Cheonan and those for Cheongju were very similar (22).
Considering the levels of these air pollutants during the study
period were relatively low, it is unlikely that the association
between ozone and respiratory symptoms was confounded
by other air pollutants like SO2, NO2, and PM10.
Our study has some limitations. Due to the small study
population and short study period, the results cannot be gen-
eralized to all asthmatics. The relationship between the mea-
sured ozone levels and the asthma symptom scores do not
fully reflect individual patient’s characteristics because the
data were not analyzed individually. In addition, all of the
subjects were severe asthmatics using medications before and
during the study period. This medication use could have
masked the inflammatory responses of asthmatic airways on
exposure to ozone and might be one of the reasons our results
did not show changes in pulmonary function parameters or
relief medication use.36 D.H. Kim, Y.S. Kim, J.S. Park, et al.
Although there are some limitations to our study, the results
suggest that exposure to ozone concentrations lower than
80 ppb influences the symptoms of patients with moderate
to severe asthma, regardless of the changes in pulmonary func-
tion or frequency of relief medication use.
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